• Company
• HK Inno.N will copromote Xigduo and Sidapvia with AZ
• by Kim, Jin-Gu Feb 1, 2024 12:38pm

• Company
• 13 of Keytruda’s indications await ‘redeliberation’
• by Eo, Yun-Ho Feb 1, 2024 12:38pm

• Company
• MSD’s rare cancer drug Welireg first prescribed in KOR
• by Eo, Yun-Ho Jan 29, 2024 06:05am

• Company
• Vemlidy dominates stagnant 300 bil. won hepatitis B market
• by Son, Hyung-Min Jan 29, 2024 06:05am

• Policy
• Referencing lowest A8 price will result in a supply crisis
• by Nho, Byung Chul Jan 29, 2024 06:05am

• Policy
• Remote GMP inspections not recognized from April
• by Lee, Hye-Kyung Jan 29, 2024 06:05am

• Company
• Will Polivy secure reimbursement approval this year?
• by Eo, Yun-Ho Jan 29, 2024 06:04am

• Policy
• Lilly’s UC drug Omvoh is soon to be approved in KOR
• by Lee, Hye-Kyung Jan 26, 2024 05:51am

• Policy
• P2T for LG Chem’s obesity drug LB54640 approved in Korea
• by Lee, Hye-Kyung Jan 26, 2024 05:51am

• Company
• New CKD drug Kerendia lands in general hospitals in KOR
• by Eo, Yun-Ho Jan 26, 2024 05:51am